Under the terms of the deal, Zydus will acquire all outstanding shares of Assertio at $23.50 per share, through a tender offer followed by a merger, the company said in a statement.

In the past 12 trading days, the market price of Biocon has appreciated by 20 per cent from a level of ₹349.65 on the BSE on ...

Twenty people in Japan who took Amgen’s rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury, according to Kissei Pharmaceutical 4547-3.13%decrease; red down ...

Residents and business owners haven’t softened their opposition to the proposed supervised drug consumption site downtown despite efforts by the province and managing organization to quell their ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

May 14 (Reuters) - EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ‌of its experimental eye disease drug Duravyu and recommended ‌the studies ...

The Trump administration has lofty expectations about the state of the pharmaceutical industry, but not everyone appears to be a believer. Recent data from the White House predicted that the ...

May 14 (Reuters) - EyePoint (EYPT.O), opens new tab said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug ‌Duravyu and ...

Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s best-selling medication. Mounjaro generated $8.7 billion for Lilly in the first ...

If you’re unsure whether you’ve taken your medication, talk with your doctor or pharmacist before taking another dose. Taking two doses could raise your risk of harmful effects or overdose. Medication ...

Jordan Peterson’s disappearance from the public eye has led to persistent speculation the celebrity shrink’s journey into fringe online wellness fads contributed to his decline. In recent years the ...

The new weight loss drug hasn’t even been formally promoted yet, its CEO says. Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and ...